Ang-2 | VEGF | HGF | bFGF | G-CSF | GM-CSF | |
---|---|---|---|---|---|---|
SVF-derived MSCs | 1,642 ± 1,157 | 329 ± 69 | 12,602 ± 1,492 | 21 ± 3 | 70 ± 13 | 3.2 ± 1.2 |
PB-positive selected monocytes | ||||||
Condition 1 | 200 ± 35 | 40 ± 5 | 7 ± 1 | 12 ± 5 | 0.6 ± 0.2 | 1.9 ± 0.2 |
Condition 2 | 186 ± 78 | 52 ± 25 | 20 ± 19 | 12 ± 2 | 7.4 ± 2.2 | 15 ± 4 |
Condition 3 | 278 ± 18 | 48 ± 15 | 137 ± 35 | 25 ± 2 | 3.4 ± 1.2 | 5 ± 2 |
Co-cultured with MSCs | 26 ± 9* | 210 ± 49 | 155 ± 71* | 34 ± 4 | 4,188 ± 2,001* | 957 ± 552* |
PB-untouched monocytes | ||||||
Condition 1 | 229 ± 36 | 46 ± 36 | 9 ± 1 | 11 ± 2 | 0.7 ± 0.3 | 1.5 ± 0.7 |
Condition 2 | 215 ± 142 | 54 ± 43 | 28 ± 23 | 16 ± 6 | 33 ± 7† | 18 ± 8 |
Condition 3 | 216 ± 25† | 61 ± 16 | 163 ± 75 | 18 ± 3 | 4.7 ± 1.4 | 4.3 ± 1.7 |
Co-cultured with MSCs | 25 ± 9* | 197 ± 96 | 134 ± 47* | 27 ± 5† | 4,321 ± 2,529* | 878 ± 514* |
SVF CD14 + cells | ||||||
Condition 2 | 220 ± 123* | 1,733 ± 193* | 18 ± 8* | 580 ± 199* | 30,895 ± 6,699* | 4,017 ± 791* |
Condition 3 | 176 ± 96*‡ | 916 ± 164*† | 13 ± 4*‡ | 341 ± 121*†‡ | 5,555 ± 3,986*† | 1,782 ± 1,001*† |